Searched for
ZYDUS WORLDWIDE
Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...16 Jun, 2026, 07.50 PM IST- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...30 May, 2026, 11.17 PM IST
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...24 May, 2026, 04.23 PM IST
- Zydus Lifesciences shares jump 6% on buyback buzz; co announces $166 mn Assertio acquisitionZydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. T...14 May, 2026, 01.19 PM IST
- Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...14 May, 2026, 11.15 AM IST
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...14 May, 2026, 01.22 AM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...01 May, 2026, 11.01 PM IST
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...21 Apr, 2026, 08.37 AM IST
- Zydus Lifesciences gets USFDA nod for 2 generic drugsThe tentative approval granted by the US Food and Drug Administration (USFDA) to the company's arm Zydus Worldwide DMCC to market Valbenazi...17 Oct, 2022, 01.52 PM IST
- Zydus gets USFDA nod to market generic antifungal medicationEfinaconazole is an antifungal used for the topical treatment of Onychomycosis of the toenails due to Trichophyton rubrum and Trichophyton ...18 Jul, 2022, 04.24 PM IST
- Zydus Cadila gets US Food and Drug Administration nod for diabetes medicationOn October 31, 2020, Zydus had filed a new drug application (NDA) with the USFDA seeking approval to market Sitagliptin base 25, 50 and 100...06 Sep, 2021, 01.09 PM IST
- Zydus Cadila launches new product for COPD patients in IndiaDrug firm Zydus Cadila on Thursday said it is launching pressurized metered dose inhaler for patients suffering from Chronic Obstructive Pu...08 Oct, 2020, 11.29 AM IST
- India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivirZydus, listed as Cadila Healthcare, joins other Indian pharmaceutical companies Cipla Ltd, Jubilant Sciences Ltd and privately held Hetero ...12 Jun, 2020, 09.56 PM IST
- Zydus gets final nod from USFDA for anti-bacterial drugZydus Cadila is a global pharmaceutical company that develops, manufactures and markets a broad range of healthcare therapies. The group em...02 Jun, 2018, 02.04 PM IST
- Cadila Healthcare settles patent litigation related to Livalo tabletsThe company and its subsidiary have finalised an agreement with Kowa Company and Nissan Chemical Industries to settle all outstanding paten...17 Jan, 2017, 02.48 PM IST
- Zydus Healthcare buys 2 ANDAs from TevaThe company said these ANDAs have been acquired by its 100 per cent subsidiary, Zydus Worldwide DMCC and will be financed through the group...20 Jun, 2016, 12.18 PM IST
- Zydus ties up with US-based research centre NIAD to develop vaccineThe Group employs over 16,500 people worldwide, including over 1,600 scientists in R&D. Cadila Healthcare is part of Zydus Group.23 Apr, 2015, 01.20 PM IST
Load More
